California Assembly Bill AB1982

California 2025-2026 Regular Session

• Introduced: 2/13/26
• Refer: 3/2/26
• Report Pass: 3/12/26
• Refer: 3/16/26
• Report Pass: 3/19/26
• Refer: 3/19/26
• Report Pass: 4/8/26
• Engrossed: 4/23/26
• Refer: 4/23/26
• Refer: 5/6/26
• Report Pass: 6/9/26
• Refer: 6/9/26

Caption

On-sale general public premises: drink lids and drug testing devices.

Impact

If approved, AB 1982 will repeal the existing sunset date for these requirements, thereby extending them indefinitely. This will lead to a significant impact on licensed public premises as they adapt to the new obligations. By ensuring that establishments provide these safety measures, the bill aims to foster a safer drinking culture, ultimately affecting operational practices within bars and other venues that serve alcohol. Additionally, it places a higher responsibility on these businesses to utilize and maintain appropriate testing devices and resources for consumer safety.

Summary

Assembly Bill 1982, introduced by Assembly Member Lowenthal, seeks to amend the Business and Professions Code regarding alcoholic beverage control. The bill mandates that establishments holding a Type 48 license must offer drink lids and drug testing devices for sale to customers. This legislation aims to enhance public safety by providing patrons with tools to detect potential drink tampering, thereby preventing drug-facilitated sexual assault, commonly referred to as 'roofing'. The bill also includes provisions for the posting of conspicuous notices to inform customers of these offerings, emphasizing awareness and prevention in social drinking environments.

Sentiment

The overall sentiment towards AB 1982 among supporters is one of promotion for public safety and proactive measures against potential drug-related crime in social settings. Proponents argue that the bill represents a necessary evolution in protective legislation aimed at vulnerable individuals in nightlife contexts. Conversely, there may be some concerns about the costs and logistics associated with implementing these requirements for businesses, particularly regarding the pricing of devices and mandatory notices, which some may regard as bureaucratic overreach.

Contention

One notable point of contention surrounding AB 1982 includes the financial implications it may impose on establishments, as they may need to secure and maintain inventories of drug testing devices while also ensuring compliance with consumer notice requirements. Additionally, the liability clause that protects businesses from being held accountable for defective or inaccurate tests of the devices may raise discussions about accountability and the extent of protection for customers. Critics might argue that while the intent is commendable, the effectiveness and practicalities of such measures could be questioned.